Delivery Order SPE2DB24D1021-SPE2DB25FERRT
- Not listed
- This federal contract award, valued at $1,596.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product used for pain management. The contract has a completion date of May 9, 2024, and is structured as a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $1,213.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4567944152 - Lidocaine 5% Patch 30s. The contract has an ultimate completion date of April 17, 2025 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a substantial Indefinite...
- This federal contract award, valued at $2,482.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product, to support DLA's Troop Support Medical program. The award has an ultimate completion date of May 9, 2024, and it is a firm fixed-price delivery order contract. This contract is not designated with any set-aside requirements, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Lidocaine 5% Patch 30S. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $6,414.30 and has an ultimate completion date of August 6, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and this award is likely part of a larger Indefinite Delivery Contract...
- This federal contract award, valued at $1,942.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product used for pain management. The contract has an ultimate completion date of April 2, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $13,611.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a prime contractor. The contract is for the delivery of 4564185827 - Lidocaine 5% Patch 30s, a pharmaceutical product, to support military treatment programs and facilities. The contract has a firm fixed price pricing type and a period of performance through April 8, 2024. No set-aside designation was used for this...
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product, with a firm fixed price of $1,558.20 and a completion date of June 18, 2025. The contract is not set aside and was awarded on June 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,539.08 contract is for the delivery of Lidocaine 5% Patch 30s, a medical product used for pain management. The contract has an ultimate completion date of February 28, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This federal contract award, valued at $4,664.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566121260 - Lidocaine 5% Patch 30s, with a completion date of October 17, 2024. The award is a Delivery Order under a Firm Fixed Price contract type. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award, valued at $5,004.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product, and has a completion date of February 3, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FERRTDelivery Order
This federal contract award, with the ID SPE2DB24D1021|SPE2DB25FERRT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,923.44, is for the delivery of Lidocaine 5% Patch 30s, a medical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of October 29, 2024. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization registered in the System for Award Management (SAM.gov) since 2002. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 10/28/24 |